# Dulaglutide-related bullous pemphigoid in a patient with type 2 diabetes: A case report.

> PubMed lists PMID 31823494 in Geriatrics & gerontology international as Case Reports, Letter, with publication-date metadata of 2019-12 (month precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-31823494-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2020-05-11
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-31823494-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-31823494-dulaglutide-v1.json
- Content SHA-256: `59d21b64bf0ff1fed23dd34dd50940251ae9ad39f918c940bc2b46dc5dbad073`

## Claims and source pins

### Headline

Dulaglutide-related bullous pemphigoid in a patient with type 2 diabetes: A case report. ([`pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80`](#source-pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80))

### Summary

PubMed lists PMID 31823494 in Geriatrics & gerontology international as Case Reports, Letter, with publication-date metadata of 2019-12 (month precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80`](#source-pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80))

### Paragraph 1

PubMed lists PMID 31823494 in Geriatrics & gerontology international as Case Reports, Letter, with publication-date metadata of 2019-12 (month precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80`](#source-pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80`](#source-pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80))

## Sources

<a id="source-pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80"></a>
- **Dulaglutide-related bullous pemphigoid in a patient with type 2 diabetes: A case report. · retained source version 1:2020-05-11:current:62a9d2797c800b8c730729cad2690cdc8bde686d630597158feb56a17cd82cac** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/31823494/) (`pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Dulaglutide-related bullous pemphigoid in a patient with type 2 diabetes: A case report." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-31823494-dulaglutide-v1.json SHA-256: 59d21b64bf0ff1fed23dd34dd50940251ae9ad39f918c940bc2b46dc5dbad073.